Opinion: Private funding – enabling Australian biomedical research
03 November, 2010 by Staff WritersThe biomedical sphere is one of the toughest areas in which to gain funding – the level of competition, coupled with limited public funding makes it difficult to take many areas of research forward. With so many subjects worthy of development, private philanthropy is a significant enabler of vital research projects across Australia.
Australia’s first iPS Type 1 diabetes cells created
03 November, 2010 by David BinningResearchers at Monash University's Institute of Medical Research have used iPS (induced pluripotent stem cells) technology to become the first in Australia to create Type 1 diabetes cells in a laboratory.
Leading antiemetic Aloxi receives PBS approval
02 November, 2010 by Staff WritersThe popular Swiss-made antiemetic post-chemo drug Aloxi (palonosetron hydrochloride) has been approved for reimbursement under the PBS.
Life science backgrounder: What is xenotransplantation?
01 November, 2010 by Staff WritersXenotransplantation is the transplantation of organs or cells from a non-human animal into a human.
Victorian Cancer Agency awards $400,000 fellowship to ovarian specialist
29 October, 2010 by Staff WritersThis year’s $400,000 Victorian Cancer Agency (VCA) Clinical Fellowship has been awarded to Dr Clare Scott from theWalter and Eliza Hall Institute (WEHI) to help advance her ground-breaking work on epithelial ovarian cancer.
Insight into how immune cells cause diabetes
27 October, 2010 by Staff WritersResearchers from Sydney's Garvan Institute of Medical Research have uncovered a mechanism by which immune cells interact, giving insight into the causes of Type 1 diabetes, where the body's own immune cells target the insulin-producing beta cells in the pancreas.
The nostril: a window to the brain
26 October, 2010 by Staff WritersA new research method developed by Australian scientist Alan Mackay-Sim and his team has the potential to shed light on the biological underpinnings of mental illnesses.
Melanoma researcher wins $1 million Pfizer research fellowship
22 October, 2010 by Staff WritersDr Mark Shackleton was named at last night’s AusBiotech 2010 Conference Dinner as the winner of the 2011 Pfizer Australia Senior Research Fellowship grant for his proposal ‘Identifying determinants of human melanoma progression’.
Garvan receives $3.7 million for cancer research
15 October, 2010 by Staff WritersThe Cancer Institute of NSW has provided funding of $3.7 million to the Garvan Institute’s Cancer Research Program to support work into determining key biomarkers for breast, prostate and pancreatic cancer.
WA researchers receive $650,000 for microRNA cancer research
15 October, 2010 by Staff WritersThe Western Australian Institute for Medical Research (WAIMR) has secured $650,000 from the Medical Research Commercialisation Fund (MRCF) to advance its work looking at the potential anti-cancer properties of the microRNA molecule miR-7 as well as the formation of a new company to act as a commercial vehicle.
New clues to memory loss could advance Alzheimer's research
13 October, 2010 by Staff WritersResearchers from Edinburgh University have published a study demonstrating the abiliy of a new experimental compound to actually restore the memories of mature mice.
ChemGenex reports positive pre-NDA meeting with FDA
07 October, 2010 by Staff WritersMelbourne biotech ChemGenex has reported positve results from its pre-NDA meeting with the FDA recently regarding advancement of the company’s OMARPO ((omacetaxine mepesuccinate) product for treating Chronic Myeloid Leukemia (CML).
New learning pathway could lead to Alzheimer’s cure
05 October, 2010 by Staff WritersAustralian and US researchers have shown that the brain uses a different physiological pathway to form memories for the first time than it uses for subsequent learning of similar information.
Researchers find genetic clues to ADHD
05 October, 2010 by David BinningParents frustrated at claims that attention deficit hyperactivity disorder (ADHD) attention deficit hyperactivity disorder (ADHD) is the result of poor diet and / or bad parenting may take some solace this week after researchers published a study showing for the first time that the brains of children with the condition are different to those without it.
Breakthrough for basal breast cancer
05 October, 2010 by Staff WritersAustralian researchers have used a novel technique for protein analysis to partly unravel the mystery of basal breast cancer.
